COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY
K-Number: K936253 · 1995-09-08
Advertisement
Device Summary
Frequently Asked Questions
What is the COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY?
COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY is a medical device that received FDA 510(k) clearance on 1995-09-08. The listed applicant is Light Diagnostics. The 510(k) number is K936253.
When did COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY receive FDA 510(k) clearance?
COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY received FDA 510(k) clearance on 1995-09-08, under 510(k) number K936253.
Who is the listed applicant for COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY?
The FDA 510(k) record lists Light Diagnostics as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY?
The FDA product code for COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY is GNM.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Light Diagnostics as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GNM)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement